According to Yahoo Finance data, TEVA has the highest book value per share of all major pharma companies and the lowest price to book value per share at barely over 1. Debt is undoubtedly a major factor but it seems to me that TEVA's reward vs. risk is quite good.
Waiting for new CEO and CFO to bring back investors who dumped the stocks. Too cheap to ignore. Buy before news comes out.
TEVA is now down the past three months. Still hoping it comes back to $36.
So, What Did Donald Do Today? I Understand that when he Returns From his Trip he is Going to Start Work on Health Care and those "Murder" High Drug Prices. Should make for some very nice share price movement, don't you think?
Current unknowns: 1) Will the new CEO be a guy respected by WS that has the experience with a big international pharmaceutical company 2) Will June phase III migraine results be positive 3) Will Cop[axone have generic competition in 2017/early 2018 4) Will the DOJ investigation leave Teva with a clean bill of health 5) Can Teva successfully sell 2 divisions and pay down 2.5-3 billion with the sales proceeds
All of these and other items are unknown at this time and wall street does not like uncertainty.
Teva has to continue to pay down debt and post solid results for a few quarters until the uncertainties are lifted. Until then, there will be a lot of volatility
Shorts seem to be swarming lately, but too late to the game. New CEO and execution of the divestures will raise the share price. The acquisition was not Teva's best work, but sure there was a plan to take care of the debt.
teva will get out of this mess they are working on new original medicine that hope they relese something soon
"Altogether, Teva could generate close to $3 billion from divesting these two non-core assets. Considering that it's still capable of producing around $5 billion in operating cash flow annually (when it's not dealing with litigation and major buyouts), Teva could safely whittle away as much as $6 billion to $7 billion of its $34.6 billion in debt over the next year if it sells these aforementioned assets and funnels a majority of its operating cash flow toward debt repayment." Not bad. Paying off about 15% of debt in 1 year. Question is, what will they do next year? Cannot keep selling revenue generating assets.
Cash-flow projected to be short of requirements. Even if it makes it, they will use every dime generated keeping the lights on. Wow, some change for a company that had ~$8b worried crazy about Copax. Cash will be close to zero for a very long time without a blockbuster hit. Wow. Let's hope US does not impinge on progress with more fines and price controls not to mention insurance companies getting in on the game. Many risks. Current price does not reflect risks IMO.
ZOMG! Awesome news! teva DOWN 2% in Israel Stock Market this Morning. While I am No Expert Trader, I would be concerned IF I was Long teva. I would expect the Dump continues.................. teva.ta enjoy.
Teva will not die however one should understand that the short & Long terms challenges are greater than short /long terms opportunities but there are many opportunities. This is a LONG TERM buy. no quick turnarounds. hard to predict the bottom but below 30 is surely a good entry point. last time it visited these levels was in 2003...
Ever wonder who is still selling? Who sells a company that generates $24B in annual revenues and $6B/Y profit and does such while its trading right AT its book valuation?!?!?
When medical costs go up, people switch to generic drugs and TEVA is the largest and best in the World, The company's stock is so cheap, even $45.00 a share is a bargain because it is worth $70.00
Wow! Awesome news!
I tend to hope TEVA already touched the buttom and from now on it will rise 💫
Nearing book value. market is voting machine in short term, but weighing machine in long term.
Classic case of AI in action. I'm here to stay and will beat the machines...
Back to 31 today
So, Do you Think Holding over the Weekend is a Good Idea? Washington has been So Unpredictable Lately, and So has TEVA Share Price. Every time you Look we hit a New Yearly Low. A Lot can Happen in 48 Hours, as you have Already Seen.
Numerous drug stocks hit hard today: ENDP, DEPO, MNK to name but a few. Still, this is no excuse for the leaders(the TEVA's, the MYL's) of the space to continue to drop(in TEVA's case, hammered again for no apparent reason). If the market is trying to sift through and find the next leaders, its doing an absolutely terrible job of it(VRX very, very green again?!?!? R U kidding!?!?!?)